RE: The PumpGreat post inequities.
i've been trying to make some sense of the possible motivations behind such posting, especially the last couple of posts you highlighted
some questions come to mind in that regard...
did the euro institution take advantage of the higher (artificially inflated?) stock price after apr 8 to dump their shares for a nice tidy & very quick $2 to $5/share profit, then go short, leaving onc with some extra cash in their treasury and the naive & newbie longs out to dry?
we know that BT & his friendly borkerage Cannacord have shown they don't have any qualms dealing with hedge funds (see Amaranth in the latest financing) who aren't necessarily committed to the long term, that will go long or short when the situation "warrants" (pardon the pun).
could management, knowing they finally had some material news to announce in the UK systemic trial approval & lievonen's appointment, have helped the pump along by accidentally tipping off the "credible" BIOEYE with their unbridled enthusiasm that some significant non-specific news was coming soon?
BIOEYE has often left the impression (if not directly stated in her posts) that her source of info usually comes straight from the horse's mouth.
Here is an example
Ulster, I think you're right about ONC being low key. Given what's going on, or about to go on, I thought the presentation by Dr. T. yesterday was, IHMO, exceptionally so.
I got the impression listening to him give the talk that he was there because he had to be, and not that it had any sort of priority.
I've had the increasing sense for a month or so that there's something else going on. I talked to Dr. T. on Tuesday last, and Dr.C. a week earlier, and there was almost a giddiness in both their manners that seemed to have had nothing to do with the topics at hand (ie Phase I, Phase II approval, NASDAQ, etc). It was almost as if they are saying, ''Oh those, yeah, well we expect to have an announcement soon, but man, are we excited about ......''
They each get quite noticeably upbeat and animated when they talk around (but not about) the way things are going otherwise.
Of course they don't mention just what those ''otherwise things'' are.
Anyway, I thought I'd pass it along. It all seems intriguing to me.
post 4225157 (October 2001)
i found that post to be quite intriguing - seems like nothing has changed in 3 and a half years - management still says very little in terms of specifics re: trials, etc. (perhaps because of their very slow progress to date, despite the small enrolments) yet they apparently are always upbeat in moving the topic of discussion "around" to "other things", but only in very general terms of course.
pumping up the price just prior to the financing would certainly help onc raise more cash with less dilution than would otherwise have been the case a month earlier, however, was part of the deal to create the expectation of ever higher prices (cue the stock price calculator?) thereby creating the demand at $8 and $9 so as to absorb the institution's shares, allowing them to then go short (having the warrants as cover), with the knowledge (despite or perhaps because of BIOEYE's "guesstimates" on timelines?) that no additional significant news would be forthcoming near term?
of course, this is all pure speculation on my part - i have no evidence (at least not yet) to support a pre-conceived conspiracy, but given the benefit of hindsight and how things actually turned out, there are some potentially disturbing coincidences here, as the chief might put it.
as to whether onc would know what that euro pp investor did with their shares, it seems BIOEYE may even have an answer for that, at least based on her previous posts.
Scoop re shorts
Deep pockets in NY decided to short up to 1,000,000 shares of ONC last Friday.
Total actually shorted, 720,000.
Expectation was that SYB could be squeezed to sell. SYB absolutely declined. Panic coverage began. Source of late day NASDAQ trades unknown.
Status 8:00am today, still 550,000 short, and no sellers of consequence willing to accomodate.
Source for all of above: ONC
Post # 4634188 (Jan. 16, 2002)
Qstocks
The NY shorter is currently in the glue to the tune of about CDN$0.75 per share, over all.
Source: ONC.
4634765
SYB go out of their way to say that...
....the ONC shares of this bought deal are not, and will not be registered under the United States Securities Act of 1933.
That means that at least this this particular block of shares may not be offered, sold or delivered in the United States.
Hmmmmmm! Interesting. I wonder how many of the ''big'' trades on the NASDAQ a few days ago were properly registered under the Act of 1933.
Oh well, I'm sure that ''someone'' interested in such matters is keeping an eye on things.
BIOEYE
4671124 (Jan 23/02)
in any event, it should be a very interesting AGM this year - perhaps BT or MC could even point out who BIOEYE is, er are?.
